DCW quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	663	539	+22.9%
EBITDA	47.5	58.0	−18.2%
EBITDA margin	7.2%	10.8%	−3.6 pts
Profit before tax	14.0	21.1	−33.4%
Net profit	10.4	13.8	−25.0%
EPS	₹0.35	₹0.47	−25.5%

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Earlier quartersAlpha Plus

Expenses
	663	542	609	520	539	475	538	474	489	500	622	398	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	7.1	5.7	5.6	4.8	4.6	4.0	5.9	4.8	6.0	6.4	5.6	4.4
	670	548	615	525	544	480	544	479	495	506	627	402
	327	335	273	264	269	260	264	263	291	290	263	275
	5.8	0.0	0.0	0.2	0.3	0.2	0.2	1.0	6.3	10.6	2.5	0.0
	63.5	−23.6	68.7	33.2	25.0	−19.8	55.7	−25.0	−32.9	−36.7	105	−60.0
	45.5	41.2	52.3	40.9	43.1	45.7	31.3	42.8	41.7	45.3	37.3	35.3
	13.6	14.8	15.4	16.2	15.5	15.1	15.8	16.2	18.4	16.9	19.9	18.0
	27.0	26.3	26.4	26.3	26.1	25.0	25.2	25.3	24.8	24.6	24.4	23.7
	173	153	150	136	144	135	131	136	147	145	150	128
	656	547	586	517	523	462	523	459	497	496	603	420
	47.5	35.8	64.6	45.2	58.0	53.7	55.9	57.0	35.4	45.2	63.4	19.4
	20.5	9.5	38.2	18.9	32.0	28.7	30.6	31.7	10.6	20.6	39.0	−4.3
Profit
	14.0	0.4	28.4	7.5	21.1	17.7	20.7	20.2	−1.8	10.1	24.6	−17.9
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−0.0	−1.1
	14.0	0.4	28.4	7.5	21.1	17.7	20.7	20.2	−1.8	10.1	24.6	−19.0
	2.7	0.1	3.0	1.4	3.6	3.1	3.6	3.5	−0.3	1.8	4.3	−3.4
	0.9	−34.3	7.2	1.3	3.6	3.2	5.7	3.3	−0.2	1.6	4.9	−3.3
	3.7	−34.2	10.3	2.6	7.2	6.3	9.4	6.8	−0.5	3.4	9.2	−6.7
	10.4	34.5	18.1	4.9	13.8	11.4	11.4	13.4	−1.2	6.7	15.3	−12.3
	10.4	34.5	18.1	4.9	13.8	11.4	11.4	13.4	−1.2	6.7	15.3	−12.3
	0.0	0.0	−0.3	0.0	0.0	0.0	−0.6	0.0	0.0	0.0	−0.2	0.0
	10.4	34.5	17.8	4.9	13.8	11.4	10.8	13.4	−1.2	6.7	15.1	−12.3
Per share
	₹0.35	₹1.17	₹0.61	₹0.17	₹0.47	₹0.39	₹0.39	₹0.45	−₹0.04	₹0.23	₹0.52	−₹0.42
	₹0.35	₹1.17	₹0.61	₹0.17	₹0.47	₹0.39	₹0.39	₹0.45	−₹0.04	₹0.23	₹0.52	−₹0.42
Other comprehensive income — detail
	0.0	0.0	−0.3	0.0	0.0	0.0	−0.6	—	—	—	—	—
	—	—	−0.5	—	—	—	—	—	—	—	−0.3	—
	0.0	0.0	−0.2	0.0	0.0	0.0	—	—	—	—	—	—
	—	—	—	—	—	—	—	0.0	0.0	0.0	−0.1	—
	—	—	—	—	—	—	−0.9	—	—	—	—	—
	0.0	0.0	—	0.0	0.0	0.0	−0.3	—	—	—	—	—
Per share — as-filed variants
	₹0.35	₹1.17	₹0.61	₹0.17	₹0.47	₹0.39	₹0.39	₹0.45	−₹0.04	₹0.23	₹0.52	−₹0.42
	₹0.35	₹1.17	₹0.61	₹0.17	₹0.47	₹0.39	₹0.39	₹0.45	−₹0.04	₹0.23	₹0.52	−₹0.42
Regulatory disclosures — filed alongside, not part of the P&L
	19.1	—	31.9	—	6.3	—	13.7	—	—	—	—	—
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	266	230	267	222	245	235	218	235	224	235	251	183
	40.2%	42.5%	43.9%	42.8%	45.5%	49.4%	40.5%	49.6%	45.8%	47.1%	40.4%	46.0%
Adjusted (ex-exceptional items) — derived
	14.0	0.4	28.4	7.5	21.1	17.7	20.7	20.2	−1.8	10.1	24.6	−17.9
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−0.0	−1.1
	10.4	34.5	18.1	4.9	13.8	11.4	11.4	13.4	−1.2	6.7	15.4	−11.6
	₹0.35	₹1.17	₹0.61	₹0.17	₹0.47	₹0.39	₹0.39	₹0.45	−₹0.04	₹0.23	₹0.52	−₹0.40

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

DCW₹45.08

DCW Limited

· Chemicals

Annual Quarterly₹ CrorePeersMANALIPETC TNPETRO AGARIND BEPLMcap ₹1,331 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	397.8	621.7	499.5	488.7	474.2	537.9	475.5	539.2	519.8	609.1	541.9	662.9
Other Income	4.4	5.6	6.4	6.0	4.8	5.9	4.0	4.6	4.8	5.6	5.7	7.1
Total Income	402.1	627.2	505.9	494.7	479.0	543.8	479.5	543.8	524.6	614.7	547.6	670.0
Expenses
+ Cost of Materials Consumed	274.8	263.5	290.2	291.5	262.8	264.2	260.1	268.7	264.1	273.0	335.4	327.3
+ Purchases of Stock-in-Trade	0.0	2.5	10.6	6.3	1.0	0.2	0.2	0.3	0.2	0.0	0.0	5.8
+ Changes in Inventories	-60.0	104.8	-36.7	-32.9	-25.0	55.7	-19.8	25.0	33.2	68.7	-23.6	63.5
+ Employee Benefit Expense	35.3	37.3	45.3	41.7	42.8	31.3	45.7	43.1	40.9	52.3	41.2	45.5
+ Finance Costs	18.0	19.9	16.9	18.4	16.2	15.8	15.1	15.5	16.2	15.4	14.8	13.6
+ Depreciation & Amortisation	23.7	24.4	24.6	24.8	25.3	25.2	25.0	26.1	26.3	26.4	26.3	27.0
+ Other Expenses	128.4	150.1	144.9	146.8	135.6	130.6	135.5	144.1	136.2	150.5	153.1	173.3
Total Expenses	420.1	602.6	495.8	496.5	458.7	523.1	461.9	522.8	517.1	586.3	547.2	656.0
EBITDA	19.4	63.4	45.2	35.4	57.0	55.9	53.7	58.0	45.2	64.6	35.8	47.5
EBIT	-4.3	39.0	20.6	10.6	31.7	30.6	28.7	32.0	18.9	38.2	9.5	20.5
Profit
PBT before Exceptional Items	-17.9	24.6	10.1	-1.8	20.2	20.7	17.7	21.1	7.5	28.4	0.4	14.0
+ Exceptional Items	-1.1	-0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Pretax Income	-19.0	24.6	10.1	-1.8	20.2	20.7	17.7	21.1	7.5	28.4	0.4	14.0
+ Current Tax	-3.4	4.3	1.8	-0.3	3.5	3.6	3.1	3.6	1.4	3.0	0.1	2.7
+ Deferred Tax	-3.3	4.9	1.6	-0.2	3.3	5.7	3.2	3.6	1.3	7.2	-34.3	0.9
Tax Expense	-6.7	9.2	3.4	-0.5	6.8	9.4	6.3	7.2	2.6	10.3	-34.2	3.7
Net Income	-12.3	15.3	6.7	-1.2	13.4	11.4	11.4	13.8	4.9	18.1	34.5	10.4
+ Net Income — Continuing Ops	-12.3	15.3	6.7	-1.2	13.4	11.4	11.4	13.8	4.9	18.1	34.5	10.4
+ Other Comprehensive Income	0.0	-0.2	0.0	0.0	0.0	-0.6	0.0	0.0	0.0	-0.3	0.0	0.0
Total Comprehensive Income	-12.3	15.1	6.7	-1.2	13.4	10.8	11.4	13.8	4.9	17.8	34.5	10.4
Per Share
Basic EPS	-0.42	0.52	0.23	-0.04	0.45	0.39	0.39	0.47	0.17	0.61	1.17	0.35
Diluted EPS	-0.42	0.52	0.23	-0.04	0.45	0.39	0.39	0.47	0.17	0.61	1.17	0.35
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	-0.6	0.0	0.0	0.0	-0.3	0.0	0.0
+ Items NOT to be Reclassified to P&L	—	-0.3	—	—	—	—	—	—	—	-0.5	—	—
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.0	0.0	0.0	-0.2	0.0	0.0
+ Tax on Items NOT to be Reclassified — alt tag	—	-0.1	0.0	0.0	0.0	—	—	—	—	—	—	—
+ Items to be Reclassified to P&L	—	—	—	—	—	-0.9	—	—	—	—	—	—
+ Tax on Items to be Reclassified	—	—	—	—	—	-0.3	0.0	0.0	0.0	—	0.0	0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	-0.42	0.52	0.23	-0.04	0.45	0.39	0.39	0.47	0.17	0.61	1.17	0.35
Diluted EPS — Continuing Operations	-0.42	0.52	0.23	-0.04	0.45	0.39	0.39	0.47	0.17	0.61	1.17	0.35
Regulatory Disclosures — filed alongside, not part of the P&L
Related-party Transactions — During the Period	—	—	—	—	—	13.7	—	6.3	—	31.9	—	19.1
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	183.0	250.9	235.4	223.9	235.4	217.8	234.9	245.2	222.3	267.4	230.1	266.3
Gross Margin %	46.01	40.35	47.12	45.82	49.64	40.49	49.40	45.48	42.77	43.90	42.46	40.18
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	-17.9	24.6	10.1	-1.8	20.2	20.7	17.7	21.1	7.5	28.4	0.4	14.0
− Exceptional Items (reconciliation)	-1.1	-0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net Income Adj (tax-effected)	-11.6	15.4	6.7	-1.2	13.4	11.4	11.4	13.8	4.9	18.1	34.5	10.4
EPS Adj	-0.40	0.52	0.23	-0.04	0.45	0.39	0.39	0.47	0.17	0.61	1.17	0.35
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Paid Up Equity Capital	59.0	59.0	59.0	59.0	59.0	59.0	59.0	59.0	59.0	59.0	59.0	59.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

DCW Q2 FY27 results (July–September 2026)

DCW (NSE: DCW) reported its Q2 FY27 results (July–September 2026). Consolidated net profit was ₹10.4 crore, down 25.0% from ₹13.8 crore in Q2 FY26 and down 70.0% from ₹34.5 crore in Q1 FY27. Revenue from operations was ₹663 crore, up 22.9% year on year and up 22.3% from the previous quarter.

Q2 FY26 results (a year earlier): 4 November 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit: ₹10.4 Cr−25.0% vs Q2 FY26−70.0% vs Q1 FY27
Revenue from operations: ₹663 Cr+22.9% vs Q2 FY26+22.3% vs Q1 FY27
Operating margin (EBIT): 3.1%−2.8 pts vs Q2 FY26+1.3 pts vs Q1 FY27EBIT ₹20.5 Cr
EBITDA: ₹47.5 Cr−18.2% vs Q2 FY26+32.7% vs Q1 FY27margin 7.2%
Earnings per share (basic): ₹0.35−25.5% vs Q2 FY26−70.1% vs Q1 FY27
Net profit margin: 1.6%−1.0 pts vs Q2 FY26−4.8 pts vs Q1 FY27

Questions

What was DCW's net profit in Q2 FY27?

Consolidated net profit was ₹10.4 crore, down 25.0% from ₹13.8 crore in Q2 FY26 and down 70.0% from ₹34.5 crore in Q1 FY27.

What was DCW's revenue in Q2 FY27?

Revenue from operations was ₹663 crore, up 22.9% year on year and up 22.3% from the previous quarter.

What was DCW's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹20.5 crore, a margin of 3.1%, against 1.8% in Q1 FY27 and 5.9% in Q2 FY26. EBITDA was ₹47.5 crore, 7.2% of revenue.

How were DCW's Q2 FY27 results?

Revenue grew from a year earlier while net profit fell: revenue was up 22.9% at ₹663 crore, and net profit was down 25.0% at ₹10.4 crore. The operating margin was 3.1%, down 2.8 percentage points from 5.9% a year earlier. Against Q1 FY27, net profit was down 70.0% and revenue up 22.3%.

What was DCW's net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹44.9 crore, up 78.2% from ₹25.2 crore in the same months a year earlier. Revenue from operations was ₹1,205 crore, up 18.7%.

When will DCW announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

What was DCW's EPS in Q2 FY27?

Basic earnings per share were ₹0.35, against ₹0.47 in Q2 FY26.

What is DCW's net profit margin?

DCW's net profit margin was 1.6% in Q2 FY27 (net profit as a share of revenue from operations), against 2.6% in Q2 FY26 (down 1.0 percentage points). For FY26 as a whole it was 2.2%.

What was DCW's net profit in FY26?

Consolidated net profit was ₹48.2 crore in FY26 (April 2025–March 2026), up 59.1% from ₹30.3 crore in FY25. It was ₹15.7 crore in FY24 and ₹192 crore in FY23: down 74.9% over three years, an average fall of 36.9% a year.

How has DCW's profit changed over the last four quarters?

Net profit by quarter: ₹4.9 crore in Q3 FY26, ₹18.1 crore in Q4 FY26, ₹34.5 crore in Q1 FY27 and ₹10.4 crore in Q2 FY27. That is ₹67.9 crore over the four quarters, up 35.8% from ₹50 crore in the four quarters before. Revenue from operations: ₹520 crore, ₹609 crore, ₹542 crore and ₹663 crore.

What was DCW's revenue in FY26?

Revenue from operations was ₹2,144 crore in FY26 (April 2025–March 2026), up 7.2% from ₹2,000 crore in FY25. It was ₹1,872 crore in FY24 and ₹2,634 crore in FY23: down 18.6% over three years, an average fall of 6.6% a year.

Where do these DCW figures come from?

From DCW's own consolidated results filings to NSE, in ₹ crore as filed. Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.